Autoimmune Encephalitis in Children: Presentation, Diagnostic Difficulties, and Outcomes in Resource-Limited Settings
Open Access
- 1 July 2026
- journal article
- Published by The Korean Child Neurology Society in Annals of Child Neurology
- Vol. 34 (3) , 215-223
Abstract
Purpose: Autoimmune encephalitis (AE) is an important noninfectious cause of pediatric encephalitis. Despite advances in the recognition of AE, many children are misdiagnosed during the early disease course, delaying treatment beyond the optimal therapeutic window. This study aimed to describe clinical characteristics, diagnostic challenges, treatment, and outcomes among pediatric patients with AE in Indonesia to inform management in resource-limited settings.Methods: This retrospective study included patients aged <18 years who were diagnosed with AE at Dr. Soetomo General Academic Hospital from January 2023 to October 2025. Diagnosis was established according to the diagnostic criteria for autoimmune encephalitis. Data on clinical characteristics, supporting examinations, treatment, and outcomes were reviewed. Functional outcomes were assessed using the modified Rankin Scale. Statistical analyses were performed using SPSS version 29.Results: The median patient age was 10 years, and seizures were the most common symptom, occurring in 13 of 14 patients. Six patients tested positive for anti–N-methyl-D-aspartate receptor antibodies. Treatment initiation was delayed, with a median time to treatment of 19 days. Among the 11 patients who completed follow-up, seven had good outcomes, defined as modified Rankin Scale scores of 0–2. However, three patients were lost to follow-up. The median hospital stay was 14 days (range, 7 to 37).Conclusion: Immunotherapy was associated with improved clinical outcomes despite delays in treatment initiation. Earlier disease recognition and improved access to diagnostic testing and immunotherapy are needed to improve the management and prognosis of pediatric patients with AE in similar healthcare settings.Keywords
This publication has 34 references indexed in Scilit:
- N-methyl-D-aspartate receptor autoantibody levels in children with intractable and non-intractable epilepsyHeliyon, 2024
- The Diagnostic Challenge and Prognosis of Autoimmune Encephalitis in Children: A Single-Center Retrospective StudyPediatric Neurology, 2023
- Current Situation of Magnetic Resonance Imaging Services in IndonesiaJournal of Medical Imaging and Radiation Sciences, 2022
- Use and Safety of Immunotherapeutic Management of N-Methyl-d-Aspartate Receptor Antibody EncephalitisJAMA Neurology, 2021
- Clinical manifestations, treatment outcomes, and prognostic factors of pediatric anti-NMDAR encephalitis in tertiary care hospitals: A multicenter retrospective/prospective cohort studyBrain and Development, 2019
- An Update on the Treatment of Pediatric Autoimmune EncephalitisCurrent Treatment Options in Rheumatology, 2018
- Autoimmune encephalitis epidemiology and a comparison to infectious encephalitisAnnals of Neurology, 2018
- The spectrum of autoimmune encephalopathiesJournal of Neuroimmunology, 2015
- Extreme delta brush guides to the diagnosis of anti-NMDAR encephalitisJournal of the Neurological Sciences, 2015
- Pediatric Anti-N-methyl-D-Aspartate Receptor Encephalitis—Clinical Analysis and Novel Findings in a Series of 20 PatientsThe Journal of Pediatrics, 2013